Ca 19-9 in the monitoring of colorectal cancer after surgery

被引：0
|
作者：
F. Franchi
C. Pastore
P. Izzo
E. Calió
机构：
[1] University of Rome ‘La Sapienza’,Department of Clinical Medicine, Oncology Unit
[2] University ‘Tor Vergata’,Department of Obstetrics and Gynecology
来源：
Medical Oncology | 2001年 / 18卷
关键词：
Colorectal cancer; CEA; Ca 19-9; marker sensitivity/specificity;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：237 / 238
页数：1
相关论文
共 50 条
  • [41] The role of periodic serum CA19-9 test in surveillance after colorectal cancer surgery
    Ryosuke Okamura
    Suguru Hasegawa
    Koya Hida
    Nobuaki Hoshino
    Kenji Kawada
    Kenichi Sugihara
    Yoshiharu Sakai
    International Journal of Clinical Oncology, 2017, 22 : 96 - 101
  • [42] Extremely high level of CA 19-9 in a patient with metastatic pancreatic cancer: Second highest level of CA 19-9 in literature
    Kizilarslanoglu, Muhammet Cemal
    Civelek, Ramazan
    Kilic, Mustafa Kemal
    Kerem, Mustafa
    Gunaydin, Yusuf
    Ulger, Sukran
    JOURNAL OF BUON, 2014, 19 (02): : 583 - 584
  • [43] CEA, TPS, CA 19-9 and CA 72-4 and the fecal occult blood test in the preoperative diagnosis and follow-up after resective surgery of colorectal cancer
    Griesenberg, D
    Nürnberg, R
    Bahlo, M
    Klapdor, R
    ANTICANCER RESEARCH, 1999, 19 (4A) : 2443 - 2450
  • [44] THE SEROLOGIC MARKER CA 19-9 AND PANCREATIC-CANCER
    NARDONE, DA
    ANNALS OF INTERNAL MEDICINE, 1989, 111 (02) : 184 - 185
  • [45] CA 19-9 in pancreatic cancer - from diagnosis to therapy
    Rainer, Klapdor
    TUMOR BIOLOGY, 2006, 27 : 19 - 19
  • [46] CA 19-9 serum course and prognosis of pancreatic cancer
    Safi, F
    Schlosser, W
    Falkenreck, S
    Beger, HG
    INTERNATIONAL JOURNAL OF PANCREATOLOGY, 1996, 20 (03) : 155 - 161
  • [47] CA 19-9 and Lewis Antigens in Pancreatic Cancer Reply
    Berger, Adam C.
    Hoffman, John P.
    Winter, Kathryn
    Regine, William
    Safran, Howard
    Abrams, Ross
    Willet, Christopher
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15) : 2573 - 2573
  • [48] CA 19-9 and CEA as markers of survival in rectal cancer
    Aires, F.
    Rodrigues, D.
    Marques, M.
    Pinto, M.
    ANNALS OF ONCOLOGY, 2020, 31 : S154 - S154
  • [49] Differences in plasma gastrin, CEA, and CA 19-9 concentration in patients with proximal and distal colorectal cancer
    Bombski, G
    Gasiorowska, A
    Orszulak-Michalak, D
    Neneman, B
    Kotynia, J
    Strzelczyk, J
    Janiak, A
    Malecka-Panas, E
    JOURNAL OF GASTROINTESTINAL CANCER, 2002, 31 (1-3) : 155 - 163
  • [50] CA 19-9 in follow-up of patients with colorectal cancer: Should it stay or should it go?
    Kotzev, Andrey
    JOURNAL OF BUON, 2019, 24 (03): : 1310 - 1311
12345